Vishva Dixit
Genentech
USA
EMBL–Wellcome Genome Campus Conference
Through the tremendous advances in the technology of mass spectrometry-based proteomics and its applications, the research has expanded to most areas of biology that deal with proteins. This conference will focus on the application of proteomics to cell biology and unraveling disease mechanisms by addressing conceptually novel ways to study long-standing questions in these fields. As most proteomics-based conferences tend to focus on analytical chemistry, the selection of biological topics is usually uneven. Therefore, this unique EMBL|Wellcome Genome Campus Conference, which is being held at EMBL Heidelberg and will alternate yearly between Heidelberg and Hinxton, will focus on biology applications and build bridges to the disciplines where the technology’s promise is still not nearly fully realised.
Genentech
USA
Max Planck Institute of Biochemistry
Germany
University of Colorado
USA
EMBL Heidelberg
Germany
EMBL-EBI Hinxton
UK
Broad Institute
USA
Goethe University Frankfurt
Germany
University of Dundee
UK
Max Planck Institute of Biochemistry
Germany
Weizzman Institute
Israel
ETH Zurich
Switzerland
Weizmann Institute
Israel
University of Washington
USA
Princeton University
USA
University of Dundee
UK
Max Planck Institute of Biochemistry
Germany
Max Planck Institute of Biochemistry
Germany
EMBL Heidelberg
Germany
Date: 7 - 9 Mar 2019
Location: EMBL Heidelberg